A trial in which rosiglitazone and glipizide were compared supports earlier findings that rosiglitazone does not have an adverse effect on the progression of coronary atherosclerosis ...

VICTORY: Rosiglitazone and Atherosclerosis The drug showed a trend toward a slowing of the progression of atherosclerosis and an overall positive effect on metabolic factors in the VICTORY study ...

Both rosiglitazone and pioglitazone are members of the thiazolidinedione (TZD) chemical class, and are associated with various side effects, including weight gain, fluid retention and oedema ...

Rosiglitazone is a drug used to help people with type 2 diabetes control their blood sugar levels. Belonging to a class of ...

Rosiglitazone (as maleate), metformin HCl; 1mg/500mg, 2mg/500mg, 2mg/1000mg, 4mg/500mg, 4mg/1000mg; tabs. Concomitant insulin: not recommended. Increased risk of lactic acidosis with topiramate ...

Researchers compared these options in a double-blind, randomized trial of rosiglitazone (Avandia), a thiazolidinedione. The manufacturer-funded study involved 4360 adults with recently diagnosed ...